Ankylosing spondylitis: open trials in Belgium

1 open trial has a site in Belgium. Registry data; only the trial team decides who can take part.

NCT04638647
An open-label, multi-center protocol for patients who have completed a previous Novartis sponsored Secukinumab study and are judged by the investigator to benefit from continued Secukinumab treatment
Trial Treatment · Phase 4 · Novartis Pharma AG
Az St-Jan Brugge-Oostende A.V., Brugge · ReumaClinic, Genk · Universitair Ziekenhuis Gent, Gent · Centre Hospitalier Universitaire de Liège, Liège · CHU Helora, Mons
Registry updated 2026-09-25

This page is not medical advice. Talk to your doctor before contacting a trial.

An open-label, multi-center protocol for patients who have completed a previous Novartis sponsored Secukinumab study and are judged by the investigator to benefit from continued Secukinumab treatment